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Abstract
Background: High-fat diet has been known to have adverse effects on metabolic markers, as well as the gut
microbiota. However, the effect of heat processing of high-fat diet, which leads to formations of advanced
glycation end products (AGEs) has not been clearly distinguished from the effect of unheated fat. This study
compared the effect of high-fat diet with heat-treated high-fat diet on adiposity, atherosclerosis and gut
microbiota composition in the caecum of apoe−/− mice.
Method: Male apoe−/− mice were fed either low-fat (LF) control diet, high-fat (40 E% saturated fat, HF) control diet,
or heat-treated high-fat (200 °C for 10 min, HT) diet, for 8 weeks. The plasma samples were used in the analysis of
Nε-carboxy-methyl-lysine (CML) and Nε-carboxy-ethyl-lysine (CEL). The heart samples were analysed for atherosclerotic
plaques, and the DNA from caecum was extracted and analysed for microbiota composition using 16S rRNA gene
sequencing on a Miseq instrument. Additionally, the functions of microbial communities were also predicted based
on the bacterial 16S rRNA gene sequence using Phylogenetic Investigation of Communities by Reconstruction of
Unobserved States (PICRUSt).
Results: Here we found that HT modifies gut microbiota composition and host adiposity. Prediction of bacterial gene
functions based on 16S rRNA gene sequence revealed that HF increased bacterial genera enriched in lipid metabolism
genes, while HT did not. Plasma CML and CEL increased 1.7 and 2.5 times, respectively, in mice fed HT as compared to
mice fed HF. Despite lower adiposity, mice fed HT maintained atherosclerosis and displayed enlarged spleens.
Conclusions: The results suggested that heat processing of high-fat diet modifies the substrates reaching the lower
gut of apoe−/− mice, resulting in different effects on gut microbiota composition. AGEs seem to maintain the effect on
atherosclerosis, despite lower adiposity, and causing enlarged spleens, which possibly reflect elevated levels of
inflammation in the body.
Keywords: High-fat diet, Heat-treated high-fat diet, Advanced Glycation End products (AGEs), Gut microbiota,
Atherosclerosis
Background
Modern diet involves heat processing of food, which
leads to formation of Maillard reaction products (MRPs).
These products are responsible for the aroma, colour,
flavour, and texture as well as deterioration of nutritional
value in the processed food and adverse health implica-
tions [1, 2]. Recently, more attention has been paid to
the health implication of Maillard reaction products,
especially those that lead to irreversible modifications
in amino acids, peptides and proteins; advanced glyca-
tion end products (AGEs) [3–6]. AGEs are suggested to
be associated to risk markers for inflammation mediated
pathological conditions; such as cardiovascular disease,
Alzheimer’s disease and diabetes-linked-complications
[5, 7–12]. The mechanism for AGEs induced toxicity can
be mediated through binding to AGE receptors (RAGE)
and inducing pro-inflammatory cascade [8, 13, 14], and
consequently associated pathological conditions. Cross link
formation affecting the structure of the protein may also
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affect the digestibility and thus modified proteins may
reach the lower gut where they can be fermented by gut
microbiota [15].
The gut microbiota is intimately involved in numerous
aspects of host physiology. The overall balance in the
gut microbiota composition is an important key factor
ensuring normal host functions [16]. Several studies
have revealed that presence or absence of gut microbiota
or some specific groups of bacteria have been found
to contribute to development of many diseases such
as type-2 diabetes [17, 18], artherosclerosis [19, 20] and
systemic inflammatory response syndrome [21]. The com-
position of the gut microbiota is known to be affected by
dietary components reaching the lower gut. So far, the role
of process induced structure alteration in proteins on the
digestibility and possible metabolism by gut microbiota is
an area that is largely unexplored.
Atherosclerosis is one form of chronic inflammatory
response to accumulation of fat in blood vessels. The
apolipoprotein E knock out (apoe−/−) mouse is an
animal model used for assessing effects of nutritional
agents on lipid metabolism, inflammation and athero-
sclerosis [22]. Apoe−/− mice have an impaired ability for
clearance of plasma lipoprotein, leading to the develop-
ment of atherosclerosis in a short time. Several studies
have been focusing on the pathological effects of high-
fat diet. High intake of dietary fat has been known to
induce several dynamic metabolic alterations, especially
atherosclerosis, as well as changes in gut microbiota
composition [17]. However, the fact that intake of fat is
usually accompanied by heat processing [23], the specific
effect of high fat intake versus the effect of AGEs has
not been clearly distinguished. In the present study, we
aimed to compare the effect of high-fat diet (40 E%
saturated fat) with heat-treated (200 °C for 10 min)
high-fat diet on adiposity, atherosclerosis and gut micro-
biota composition in the caecum of apoe−/− mice. More-
over, the study compared the possible effect of intake of
high-fat diet on the above mentioned end points by
comparing with intake of low-fat diet. Additionally, the
functions of microbial communities were also predicted
based on the bacterial 16S rRNA gene sequence using a
recently developed software, Phylogenetic Investigation




Male apoe−/− mice (Scanbur AB, Karlslunde, Denmark),
6 weeks of age, were adapted to the environment at the
animal facility for 2 weeks before starting the experi-
ment. At the age of 8 weeks, the mice were randomly
divided into three weight-matched groups (n = 10, five
mice/cage). The mice were fed low-fat (LF) control diet,
high-fat (HF) control diet, or heat-treated high-fat (HT)
diet. A picture of HF and HT is available as Additional
file 1: Figure S1. The mice were weighed every week.
After 8 weeks, the mice were anesthetized with iso-
fluorane (Abbott Scandinavia AB, Solna, Sweden) and
terminated by heart puncture. The liver, spleen and
epididymal fat pads were weighed. Blood plasma, heart,
and caecum were collected and frozen at −40 °C until
further analyses. The plasma samples were used in the
analysis of CML and CEL. The heart samples were ana-
lysed for atherosclerotic plaques, and the DNA from
caecum was extracted and analysed for microbiota
composition using 16S rRNA gene sequencing on a
Miseq instrument.
High performance liquid chromatography coupled to
tandem mass spectrometry for determination of CML and
CEL
Plasma samples (50 μL) were hydrolysed for 12 h at
110 °C using 6 M HCl, together with isotope labelled
d4-CML and d4-CEL as internal standard (Larodan
Fine Chemicals AB, Malmö Sweden), and analysed
using high-pressure liquid chromatography mass spec-
trometry (HPLC-MS/MS). The chromatographic separ-
ation of CML and CEL in the hydrolysed samples was
performed using Accela UHPLC pump with auto-
injector. Detection was performed using a LTQ Velos-
Pro Orbitrap massspectrometer (Thermo Scientific,
Waltham, USA) run in positive electrospray ionization
ion trap tandem mass spectrometry (MS/MS) mode,
detecting two selective-reaction monitoring (SRM)
transitions for each analyte, and internal standard. The
Xcalibur software (Thermo Scientific) was used both
for data acquisition and evaluation. Solid phase extrac-
tion, chromatographic parameters, ion source param-
eter and the SRM transitions are the same as described
in Tareke E. et al. [25].
Quantification of atherosclerosis
Frozen 10 μm sections of the aortic root region of the
heart were prepared using a cryostat (Leica CM 1950,
Leica Biosystems, Nusslock, Germany) and stained with
Oil Red O (Histolab, Gothenburg, Sweden) and haema-
toxylin (Mayer’s HTX, Histolab, Gothenburg, Sweden).
Amount of atherosclerotic plaques covering the vessel
area was quantified by a blinded observer using Bio-
PixQ 2.0 (Biopix software, Gothenburg, Sweden). Three
sections/mouse, with well-oriented root regions and all
three valve cusps present, were evaluated.
Caecal microbiota composition
A total of 22 caecal samples (LF (n = 4), HF (n = 8), HT
(n = 9)) were used in the microbiota analysis. Caecal
tissue and content were thawed on ice and DNA was
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extracted using the QIAamp DNA Stool Mini Kit
(Qiagen), with an addition of a bead beating step. Sterile
glass beads (1 mm) were added in combination with
stool lysis buffer and cell disruption was performed for
2 × 2 min at 25 Hz using a TissueLyser (Qiagen), followed
by a heating step at 95 °C for 5 min. After lysis, DNA-
damaging substances and PCR inhibitors were removed
using InhibitEX tablet (provided with the kit) and the
DNA was purified on QIAamp Mini spin columns. A
normalized input of 5 ng/μL of the DNA was used in PCR
reactions where 16S rRNA genes were amplified prior to
sequencing.
The V1-V3 regions of 16S rRNA genes were amplified
using a limited cycle PCR with forward and reverse
primers containing Illumina adapter sequences and dual-
index barcodes used for tagging each sample, primer
sequences are listed in Table 1. Paired-end sequencing
with a read length of 2×300 bp was performed on a Miseq
Instrument (Illumina, Inc, San Diego, California) using a
Miseq v3 reagent kit (Illumina, Inc, San Diego, California).
Sequences were analysed using Quantitative Insights into
Microbial Ecology (QIIME), as previously described [26].
The Operational Taxonomic Units (OTUs) were picked
using a closed-reference OTU picking with UCLUST
[27] algorithm against the Greengenes [28] database
(version 13_8), pre-clustered at 97 % identify. After
quality filtering, a total of 2,280,567 reads were included
for downstream analyses and an average of 103,662 se-
quences (SD: 18,962) were assigned to each sample (ran-
ging from 67,817 to 145,015 sequences). The relative
abundances of bacterial taxa at phylum and genus levels
were thereafter compared between groups. To correct for
sampling depth differences, 67,817 reads/sample were
randomly selected and utilized for further calculation of
alpha-diversity and weighted and unweighted Unifrac as
well as correlations between the gut microbiota and differ-
ent metabolic markers.
Prediction of bacterial metagenomes using PICRUSt
The bacterial metagenomes were reconstructed based
on the bacterial 16S rRNA gene sequence using the
open-source software, PICRUSt [24]. The OTU table
generated in QIIME from the 16S sequencing data at
67,817 rarefied sequences per sample was used as an
input. The copy number per OTU was normalized before
the metagenome was predicted using Kyoto Encyclopedia
of Genes and Genomes (KEGG) database [29]. The output
from metagenome prediction was an annotated table of
predicted gene family counts for each sample, where
gene families were grouped by KEGG Orthology (KO)
identifiers.
Statistical analyses
One-way analysis of variance (ANOVA) was used to
calculate the differences in metabolic markers in differ-
ent groups of mice using Graphpad Prism 6. Differences
in within-community richness (α-diversity) were calcu-
lated in QIIME using a non-parametric t-test and the
P-values were corrected for multiple comparisons using
False Discovery Rate (FDR) correction [30]. Differences
in community composition among groups of samples
(β-diversity) were analyzed using the non-parametric
analysis of similarity (ANOSIM) [31] statistical test in
QIIME on both unweighted- and weighted Unifrac
phylogenetic metrics. Graphpad Prism 6 was also used
to identify significant differences in taxonomic distribu-
tions at phylum and genus levels between the groups of
mice using two-way ANOVA and the Holm-Sidak method
of correction for multiple comparisons. All the differences
were considered to be significant at P < 0.05. Moreover,
linear discriminant analysis (LDA) effect size (LEfSe) ana-
lysis [32] was performed to identify differentially abundant
bacterial taxa (from phylum to species level) as well as the
predicted metagenomes in each group of mice. A strict
version of LEfSe was used, the discovered bacterial taxa
and predicted genes with LDA score higher than two were
considered to be enriched in the respective group as
compared to all other groups. Partial Least Squares
(PLS) Regression analysis was performed using SIMCA14
(Umetrics, Umeå, Sweden) and PLS loading score scatter
plots were plotted to illustrate the associations between
the parameters. Pearson’s correlation was calculated for
each pairwise combination of bacterial genera versus rela-
tive spleen weight, plasma CEL and CML, and athero-
sclerosis plaque using Graphpad Prism 6 and the P-values
were then corrected by Benjamini-Hochberg procedure
for multiple comparisons [30, 33].
Results
Biomarkers
Considering no difference in food consumption of the
mice in different groups (Fig. 1a), mice fed HF had
significantly higher body weight at the end point as
compared to mice fed LF (P < 0.001, Fig. 1b). The liver
weight did not differ between groups (Fig. 1c), while the
epididymal fat pad weight was significantly lower in the
HT and LF groups compared to the HF group (Fig. 1d).
Relative spleen weight was significantly higher in HT
mice as compared to HF mice (P < 0.05, Fig. 1e). Athero-
sclerotic plaque size (% of vessel area) was higher in HF
and HT as compared to LF (both P < 0.05, Fig. 1f ). Ana-
lysis of Advanced glycation end products (CML and
Table 1 Primer sequences for amplification of 16S rRNA genes,
amplicon length 507 bp
16S Amplicon PCR Forward Primer 27F AGAGTTTGATCCTGGCTCAG
16S Amplicon PCR Reverse Primer 534R ATTACCGCGGCTGCTGG
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CEL levels) in plasma of mice revealed significant in-
creases in levels of CML and CEL in plasma of HT mice
as compared to LF and HF (all P < 0.05, Fig. 1g). CML
increased 1.7 times in HT mice as compared to LF and
HF, while CEL increased 3.5 and 2.5 times in HT as
compared to LF and HF, respectively. There was no
significant difference in plasma CML and CEL levels





Fig. 1 Different biomarkers in mice fed LF, HF and HT. a Food consumption (g/week/cage). b Mice body weight at end point (g). c Relative liver
weight (g/g body weight). d Relative epididymal fat pad weight (g/g body weight). e Relative spleen weight (g/g body weight). f Percentage
of atherosclerotic plaque size (%). g Plasma levels of AGEs products, CML and CEL (μg/ml). One-way ANOVA was used to calculate significance
among the different groups (*P < 0.05, **P < 0.01)
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Microbial diversity indices
Estimation of α-diversity of bacterial 16S rRNA gene at
the sequence number of 67,817 sequences/sample (Fig. 2a)
demonstrated that HF had a tendency for decreased
α-diversity as compared to LF. Moreover, HT lowered
the α-diversity even more as the observed OTUs and
phylogenetic diversity whole tree (PD whole-tree) in-
dices showed significant differences between HT and
LF (P < 0.05), although there was no significant differ-
ence with Chao1 index. ANOSIM analyses of both un-
weighted and weighted Unifrac revealed significant
differences between the communities of the mice in the
three treatment groups (P < 0.01 and P < 0.05, respect-
ively). Principle coordinate analysis (PCoA) plots for
unweighted and weighted Unifrac are shown in Fig. 2b
and c, respectively.
Phylum-level taxonomic distributions
Relative abundance at phylum-level (Fig. 2d) revealed
that Firmicutes was found to be the most dominant
phylum in all groups and was followed by Bacteroidetes.
The level of Firmicutes was significantly higher in HT
than LF and HF (both P < 0.01), whereas the level of
Bacteroidetes was significantly lower in HT than LF and
HF (P < 0.001 and P < 0.01, respectively).
Genus-level taxonomic distributions
The most abundant genera presented in the mice (more
than 5 % relative abundance) are shown in Fig. 2e.
As compared to LF, HF significantly increased Mucis-
pirillum (P < 0.05) and unclassified family of Clostri-
diales (P < 0.05) and reduced unclassified genus of S24-7
(P < 0.001), while similar effects were observed in HT with
significant increase in the relative abundance of unclassi-
fied family of Clostridiales (P < 0.001) and significant
decrease in the relative abundance of unclassified genus of
S24-7 (P < 0.01). Moreover, a significant decrease of an
unclassified genus of Rikenellaceae (P < 0.001) was also
observed in HT, as compared to LF. In addition, HT was
found to reduce the relative abundance of an unclassified
genus of Rikenellaceae (P < 0.001) as well as to increase
the relative abundance of Allobaculum (P < 0.001) and
unclassified family of Clostridiales (P < 0.001) as compared
to HF.
Differences in bacterial composition between groups of
treatment using LEfSe
The strict version of LEfSe (all against all) detected 24
bacterial clades showing statistically significant differ-
ences between different groups of treatment with LDA
scores higher than two (Fig. 3a). A Cladogram of these
bacterial taxa is shown in Additional file 2: Figure S2.
The most enriched bacteria in LF were Sutterella (from
phylum to genus), Anaeroplasma (from phylum to genus),
Adlercreutzia and Lactobacillus. Mucispirillum schaedleri
(from phylum to species) and Lactococcus (from family to
genus) were found to be the most enriched bacteria in HF
while Allobaculum (from order to genus) was found to be
enriched in HT.
Prediction of functional structure of genes based on 16S
gene information using PICRUSt
By applying PICRUSt to the 16S sequencing data, a total
of 328 genes were predicted to be involved in different
functions (data not shown). Assigning the strict version
(all against all) of LEfSe to the predicted genes from
PICRUSt, detected a total of 11, 9 and 5 genes enriched
in LF, HF and HT, respectively, with LDA scores higher
than two (Fig. 3b). Of these, 7, 8 and 4 genes, enriched
in LF, HF and HT, respectively, were involved in me-
tabolism. Predicted metabolism genes enriched in LF
encoded for metabolism of two amino acid groups;
arginine and proline (KO00330), glycine, serine and threo-
nine (KO00260), energy metabolism, particularly for me-
thane metabolism (KO00680), enzyme families, especially
for peptidases, and cofactors and vitamins, especially for
vitamin B6 (KO00750). Predicted genes encoding for
lipid metabolism, especially for lipid biosynthesis pro-
teins (KO01004) and glycerophospholipid (KO00564)
were enriched in HF. Moreover, metabolism of pyruvate
(KO00620), lysine biosynthesis (KO00300), beta-alanine
(KO00410), as well as pantothenate and CoA biosyn-
thesis (KO00770) were also enriched in HF. These
genes enriched in HF were shown to be involved in a
cascade of the fatty acid biosynthesis KEGG pathway.
Predicted genes encoding for carbohydrate metabolism;
fructose and mannose metabolism (KO00051) and pen-
tose and glucuronate interconversions (KO00040), energy
metabolism encoding for photosynthesis proteins and an
unclassified metabolism (no KO number) were enriched
in HT.
Additionally, genes enriched in LF were involved in
genetic information, especially for replication and repair
of chromosome, ribosome biogenesis and an unclassified
translation protein. A gene enriched in HF was involved
in cellular processes, especially for cell growth and death
and a gene enriched in HT was involved in an unclassi-
fied function (Fig. 3b).
Gut microbiota and metabolic biomarkers
Loading and score scatter (Fig. 4) PLS plots illustrated
associations between the gut microbiota and different
biomarkers as well as revealed separate clusters of the
mice by different treatments (Fig. 4, small panel). The re-
sults supported the LEfSe results (Fig. 3a and Additional
file 2: Figure S2) where those bacteria enriched in different
groups of treatment were located in the corresponding
area of the PLS plot (Fig. 4). Sutterella, Anaeroplasma,
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Fig. 2 (See legend on next page.)
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Adlercreutzia and Lactobacillus which were found to be
enriched in LF were located in the lower component of
the PLS plot. Mucispirillum and Lactococcus enriched in
HF were located in the upper right component, while
Allobaculum was located in the upper left component of
the PLS plot. Correlations between the gut microbiota and
different biomarkers were also analyzed. Relative spleen
weight was found to be positively correlated with Dehalo-
bacterium (P < 0.01), Clostridium (P < 0.05), Prevotella
(P < 0.05), unclassified family of Clostridiales (P < 0.05)
and negatively correlated with unclassified genus of
Rikenellaceae (P < 0.05) (Figs. 4 and 5). Plasma CEL
and CML levels were located in the right component
of and close to the relative spleen weight on the PLS
plot. These suggested positive correlations between
plasma CML and CEL versus relative spleen weight,
and thus versus those bacterial genera that correlated
with spleen weight, although the correlations were not
statistically significant after correction for multiple correc-
tions. No correlation was found between the gut micro-
biota and amount of atherosclerotic plaques.
Discussion
The findings from this study revealed that heat process-
ing of fat led to changes in its effects on metabolic
markers and the gut microbiota in apoe−/− mice as com-
pared to unheated fat. Mice fed HT displayed elevated
circulating levels of CML and CEL as well as enlarged
spleens, to a higher extent than mice fed HF. Enlarge-
ment of the spleen has previously been observed even in
healthy mice with intra-peritoneal administration of
RAGE and this has been suggested to be exerted
through stimulation of adaptive immune system in re-
sponse to inflammation [34]. Interestingly, the amounts
of atherosclerotic plaque were similar in HF and HT,
which were both higher than LF. The amount of athero-
sclerotic plaques was anticipated to be higher in mice
fed HT as heat processing of fat would add up the effect
of AGEs to the effect of fat on atherosclerosis. The lower
epididymal fat-pad weight observed in HT mice, to the
same level as in LF mice, could possibly provide an ex-
planation. Chemical modifications of fat by heat-
treatment might abate the effect of unheated fat, leaving
a b
Fig. 3 LDA score plot of bacterial taxa (a) and genes (b) with LDA scores higher than 2. Bacterial taxa and genes enriched in LF are in yellow,
HF in blue and HT in red
(See figure on previous page.)
Fig. 2 Diversity indices and distributions at phylum and genus levels of the gut microbiota in mice fed LF, HF and HT. a Alpha rarefaction curve
(whole-tree PD) showing differences in within-community richness (α-diversity). b Unweighted and c Weighted UniFrac PCoA plots showing
differences in community composition among groups of mice (β-diversity). d Relative abundance of the gut microbiota at phylum. e Relative
abundance of the most abundance genera (>5 % relative abundance). Reads normalized to 67,817 sequences/sample
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only the effect of AGEs on atherosclerosis. Thus, HT
mice reached similar levels of atherosclerosis as HF
mice despite lower adiposity, which may suggest an
additive effect of AGEs on atherosclerosis in the HT
mice. Heat-treated LF has not been included in this
study as the aim was only to compare the effects of
fat and heat-treatment of HF (HT), using LF as a
baseline control. However, heat-treatment of LF diet
may provide more insight into the role of fat and
AGEs on atherogenesis.
The results from 16S sequencing of caecal samples
showed that HF and HT had an impact on the compos-
ition of the gut microbiota in the mice. Both HF and HT
lowered the diversity of the gut microbiota, although the
change was only significant with HT. The most dominant
phyla in all groups were Firmicutes and Bacteroidetes,
whose relative abundance were significantly altered with
HT, as well as with HF but to a lesser extent. An imbal-
anced ratio of Firmicutes and Bacteroidetes has been
found to be associated with risk factors of obesity in both
animals and humans. High dimensional comparison using
LEfSe analysis showed that both HF and HT mice differed
in their gut microbiota composition and functions, as
compared to each other and to LF mice. The LF group
had a high diversity of bacterial genera from different
phyla. Although most groups of bacteria found enriched
in LF are not well known regarding their roles for the host,
the predicted gene functions revealed increases of genes
involved in a broad range of metabolism pathways includ-
ing amino acids, enzymes, as well as cofactors and vita-
mins. Mucispirillum found enriched in the mice fed HF, is
one of the putative mucin degraders [35] and has been
Fig. 4 Loading (big panel) and score scatter (small panel) PLS plots showing correlations between the gut microbiota and different biomarkers.
Bacterial genera are shown in small circles and colored by the phylum they belong to (green, Actinobacteria; dark blue, Bacteroidetes; red, Cyanobacteria;
yellow, Deferribacteres; light blue, Firmicutes, purple, Proteobacteria; orange, Tenericutes; pink, Verrucomicrobia). Metabolic biomarkers are shown in black
stars. Each circle in score scatter plot (small panel) represents each mouse and is colored by the group they belong to (yellow, LF; blue, HF; red, HT)
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found in a study of Belzer et al., to be involved in
the onset of symptomatic colitis in mice [36]. Inter-
estingly, the lactic acid bacteria, Lactococcus, found
enriched also in the mice fed HF, has been found in
a study of Parks et al., to have positive correlation
with body fat percentage gain in mice fed high-fat,
high-sucrose diet [37]. Although genes enriched in HF
mice were encoded for several metabolism pathways, it is
remarkable that most of these were involved in a cascade
of a fatty acid synthesis pathway. Some bacteria have been
known to synthesize glycerophospholipid on the inner
leaflet of the inner membrane and different lipid bio-
synthetic mechanisms have previously been defined
[38]. These bacterial genera could therefore generate
even more fat to the host’s energy metabolism. In
addition, the gut microbiota composition has also been
shown to play a role in how much energy is harvested
from the diet [39–41], and indeed, mice fed HF had
significantly higher epididymal fat pad weight, as well
as slightly higher body weight than mice fed HT. Inter-
estingly, Allobaculum which has previously been found
to be decreased in mice fed high-fat diet [37, 42], be-
came enriched in HT mice in this study. Although
these studies showed somewhat similar 16S gene results
as observed in this current study, it is worth mention-
ing that some of them were performed on animal faeces
as opposed to caecum and these two locations in the
gut may harbour different bacterial species. Together
with the finding that no bacterial genes encoding for
lipid metabolism were enriched in mice fed HT, we
hypothesize that heat processing of fat changed the
chemical properties of the fat, allowing different sub-
strates to reach the lower gut. However, the exact
mechanism of how heat-treated fat appears to be less
accessible to the gut microbiota than unheated fat
needs further investigation.
Conclusions
In conclusion, intake of high-fat diet led to increased
adiposity, decreased microbiota diversity and altered gut
microbiota composition. Chemical modifications of high-
fat diet by heat processing seemed to reduce the substrates
available for members of the gut microbiota having lipid
metabolism genes, resulting in lower adiposity. However,
the overall alterations of the gut microbiota are still to-
wards those associated with risk factors of obesity. More-
over, AGEs formed in HT could be a possible cause of
spleen enlargement, which possibly reflect elevated
levels of inflammation in the body. Lower intake of
heat-processed food may need to be taken into consid-
eration when developing a dietary preventative approach
of the metabolic syndrome.
Ethics approval
The study was approved by the local ethical review
committee for animal experiments in Lund, Sweden
(approval number M-295-12).
Fig. 5 Linear regression plots with Pearson’s correlation coefficient (r) of bacterial genera significantly correlated with relative spleen weight.
Dehalobacterium, Clostridium, Prevotella, unclassified family of Clostridiales and unclassified genus of Rikenellaceae were significantly correlated
with relative spleen weight. Pearson’s correlations with P < 0.05 after correction for multiple comparison using Benjamini-Hochberg procedure
was considered to be significant
Marungruang et al. Nutrition & Metabolism  (2016) 13:22 Page 9 of 11
Additional files
Additional file 1: Figure S1. Unheated (left) and heat-treated (200 °C
for 10 min, right) high-fat diets. (PDF 241 kb)
Additional file 2: Figure S2. Cladogram plot showing bacterial taxa
with LDA scores higher than two using strict version of LEfSe. Different
colors represent the most abundant taxa in different groups of mice
(yellow indicating LF, red indicating HF and blue indicating HT). Circles
represent phylogenetic levels from phylum to genus. The sizes of the
circle are proportional to the taxon’s abundance. (PDF 436 kb)
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